RSVAX vs. ACLAX

Last updated Jun 3, 2026

RSVAX (Victory RS Value Fund) and ACLAX (American Century Mid Cap Value Fund A Class) are both Mid Cap Value Equities funds. Over the past 10 years, RSVAX returned 9.09%/yr vs 8.55%/yr for ACLAX. Their correlation of 0.91 suggests significant overlap in exposure. RSVAX charges 1.30%/yr vs 1.22%/yr for ACLAX.

Performance

RSVAX vs. ACLAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Victory RS Value Fund (RSVAX) and American Century Mid Cap Value Fund A Class (ACLAX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RSVAX achieves a 5.63% return, which is significantly lower than ACLAX's 7.11% return. Over the past 10 years, RSVAX has outperformed ACLAX with an annualized return of 9.09%, while ACLAX has yielded a comparatively lower 8.55% annualized return.

RSVAX

• 1D: -0.63%
• 1M: -1.63%
• YTD: 5.63%
• 6M: 6.54%
• 1Y: 12.13%
• 3Y*: 10.27%
• 5Y*: 6.17%
• 10Y*: 9.09%

ACLAX

• 1D: -0.19%
• 1M: 0.51%
• YTD: 7.11%
• 6M: 7.56%
• 1Y: 15.50%
• 3Y*: 10.38%
• 5Y*: 6.46%
• 10Y*: 8.55%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RSVAX vs. ACLAX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
RSVAX Victory RS Value Fund	5.63%	4.58%	12.58%	7.63%	-2.98%	27.30%	-2.60%	31.36%	-10.84%	17.37%
ACLAX American Century Mid Cap Value Fund A Class	7.11%	8.52%	8.18%	5.93%	-1.53%	23.01%	1.44%	28.55%	-12.93%	11.31%

Correlation

The correlation between RSVAX and ACLAX is 0.89, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.89
Correlation (3Y) Calculated over the trailing 3-year period	0.89
Correlation (5Y) Calculated over the trailing 5-year period	0.91
Correlation (10Y) Calculated over the trailing 10-year period	0.92
Correlation (All Time) Calculated using the full available price history since Jan 14, 2005	0.91

The correlation between RSVAX and ACLAX has been stable across timeframes, ranging from 0.89 to 0.92 - a consistent structural relationship.

Return for Risk

RSVAX vs. ACLAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RSVAX

RSVAX Risk / Return Rank: 14
RSVAX Sharpe Ratio Rank: 13
RSVAX Sortino Ratio Rank: 13
RSVAX Omega Ratio Rank: 12
RSVAX Calmar Ratio Rank: 16
RSVAX Martin Ratio Rank: 18

ACLAX

ACLAX Risk / Return Rank: 20
ACLAX Sharpe Ratio Rank: 19
ACLAX Sortino Ratio Rank: 21
ACLAX Omega Ratio Rank: 18
ACLAX Calmar Ratio Rank: 21
ACLAX Martin Ratio Rank: 20

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RSVAX vs. ACLAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Victory RS Value Fund (RSVAX) and American Century Mid Cap Value Fund A Class (ACLAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RSVAX	ACLAX	Difference
Sharpe ratio Return per unit of total volatility	0.98	1.27	-0.29
Sortino ratio Return per unit of downside risk	1.49	1.96	-0.47
Omega ratio Gain probability vs. loss probability	1.17	1.22	-0.05
Calmar ratio Return relative to maximum drawdown	1.47	1.73	-0.26
Martin ratio Return relative to average drawdown	5.04	5.54	-0.51
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RSVAX vs. ACLAX - Sharpe Ratio Comparison

The current RSVAX Sharpe Ratio is 0.98, which is comparable to the ACLAX Sharpe Ratio of 1.27. The chart below compares the historical Sharpe Ratios of RSVAX and ACLAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	RSVAX	ACLAX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.98	1.27	-0.29
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.34	0.44	-0.10
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.48	0.49	-0.02
Sharpe Ratio (All Time) Calculated using the full available price history	0.41	0.48	-0.08

Drawdowns

RSVAX vs. ACLAX - Drawdown Comparison

The maximum RSVAX drawdown since its inception was -59.23%, which is greater than ACLAX's maximum drawdown of -51.37%. Use the drawdown chart below to compare losses from any high point for RSVAX and ACLAX.

Drawdown Indicators

	RSVAX	ACLAX	Difference
Max Drawdown Largest peak-to-trough decline	-59.23%	-51.37%	-7.86%
Max Drawdown (1Y) Largest decline over 1 year	-7.81%	-8.50%	+0.69%
Max Drawdown (3Y) Largest decline over 3 years	-17.98%	-14.67%	-3.31%
Max Drawdown (5Y) Largest decline over 5 years	-23.58%	-17.55%	-6.03%
Max Drawdown (10Y) Largest decline over 10 years	-43.49%	-39.24%	-4.25%
Current Drawdown Current decline from peak	-2.50%	-2.37%	-0.13%
Average Drawdown Average peak-to-trough decline	-13.82%	-6.26%	-7.56%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.27%	2.65%	-0.38%

Volatility

RSVAX vs. ACLAX - Volatility Comparison

Victory RS Value Fund (RSVAX) and American Century Mid Cap Value Fund A Class (ACLAX) have volatilities of 3.02% and 2.94%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RSVAX	ACLAX	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.02%	2.94%	+0.08%
Volatility (6M) Calculated over the trailing 6-month period	8.44%	8.45%	-0.01%
Volatility (1Y) Calculated over the trailing 1-year period	11.94%	11.88%	+0.06%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.10%	14.65%	+3.45%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.20%	17.48%	+1.72%

RSVAX vs. ACLAX - Expense Ratio Comparison

RSVAX has a 1.30% expense ratio, which is higher than ACLAX's 1.22% expense ratio.

Dividends

RSVAX vs. ACLAX - Dividend Comparison

RSVAX's dividend yield for the trailing twelve months is around 8.36%, less than ACLAX's 13.23% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ACLAX American Century Mid Cap Value Fund A Class	13.23%	14.24%	8.53%	5.01%	14.77%	15.72%	1.62%	1.23%	14.17%	9.25%	3.82%	10.86%
RSVAX Victory RS Value Fund	8.36%	8.83%	9.89%	6.48%	6.33%	14.14%	1.93%	7.38%	15.47%	25.04%	12.47%	9.35%

Frequently Asked Questions

Can I hold both RSVAX and ACLAX in my portfolio?

RSVAX and ACLAX have a correlation of 0.89, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RSVAX or ACLAX?

RSVAX has higher volatility (3.02%) compared to ACLAX (2.94%). In terms of maximum drawdown, RSVAX dropped -59.23% vs ACLAX's -51.37%.

Which has better risk-adjusted returns?

ACLAX currently has the higher Sharpe Ratio (1.27 vs 0.98), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.